Literature DB >> 23206812

Endoscopic submucosal dissection for residual early gastric cancer after endoscopic submucosal dissection.

Makoto Higashimaya1, Shiro Oka, Shinji Tanaka, Norifumi Numata, Yoji Sanomura, Shigeto Yoshida, Koji Arihiro, Kazuaki Chayama.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23206812     DOI： 10.1016/j.gie.2012.09.003

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN： 0016-5107            Impact factor:   9.427


× No keyword cloud information.
  16 in total

1.  Clinical significance of endoscopic ultrasonography in diagnosing invasion depth of early gastric cancer prior to endoscopic submucosal dissection.

Authors:  Kazutaka Kuroki; Shiro Oka; Shinji Tanaka; Naoki Yorita; Kosaku Hata; Takahiro Kotachi; Tomoyuki Boda; Koji Arihiro; Kazuaki Chayama
Journal:  Gastric Cancer       Date:  2020-06-22       Impact factor: 7.370

2.  Secondary endoscopic submucosal dissection for residual or recurrent tumors after gastric endoscopic submucosal dissection.

Authors:  Shu Hoteya; Toshiro Iizuka; Daisuke Kikuchi; Toshifumi Mitani; Akira Matsui; Osamu Ogawa; Tsukasa Furuhata; Satoshi Yamashta; Akihiro Yamada; Mitsuru Kaise; Naohisa Yahagi
Journal:  Gastric Cancer       Date:  2013-12-06       Impact factor: 7.370

3.  Long-term prognosis after endoscopic submucosal dissection for early gastric cancer in super-elderly patients.

Authors:  Yoshikazu Yoshifuku; Shiro Oka; Shinji Tanaka; Yoji Sanomura; Tomohiro Miwata; Norifumi Numata; Toru Hiyama; Kazuaki Chayama
Journal:  Surg Endosc       Date:  2016-02-05       Impact factor: 4.584

4.  Long-term Outcomes of Additional Endoscopic Treatments for Patients with Positive Lateral Margins after Endoscopic Submucosal Dissection for Early Gastric Cancer.

Authors:  Tae-Se Kim; Byung-Hoon Min; Yang Won Min; Hyuk Lee; Poong-Lyul Rhee; Jae J Kim; Jun Haeng Lee
Journal:  Gut Liver       Date:  2021-09-01       Impact factor: 4.321

5.  Risk factors for local recurrence in patients with positive lateral resection margins after endoscopic submucosal dissection for early gastric cancer.

Authors:  Tae Kyun Kim; Gwang Ha Kim; Do Youn Park; Bong Eun Lee; Tae Yong Jeon; Dae Hwan Kim; Hong Jae Jo; Geun Am Song
Journal:  Surg Endosc       Date:  2014-12-06       Impact factor: 4.584

6.  Clinical outcomes of early gastric cancer with lymphovascular invasion or positive vertical resection margin after endoscopic submucosal dissection.

Authors:  Geum Youb Noh; Ha Ra Ku; Youn Joo Kim; Su Cheol Park; Jin Kim; Chul Ju Han; Yu Chul Kim; Ki Young Yang
Journal:  Surg Endosc       Date:  2014-12-06       Impact factor: 4.584

7.  Repeat endoscopic submucosal dissection for recurrent gastric cancers after endoscopic submucosal dissection.

Authors:  Yuto Shimamura; Naoki Ishii; Kaoru Nakano; Takashi Ikeya; Kenji Nakamura; Koichi Takagi; Katsuyuki Fukuda; Koyu Suzuki; Yoshiyuki Fujita
Journal:  World J Gastrointest Endosc       Date:  2013-12-16

8.  Risk factors and management of positive horizontal margin in early gastric cancer resected by en bloc endoscopic submucosal dissection.

Authors:  Norifumi Numata; Shiro Oka; Shinji Tanaka; Kenichi Kagemoto; Yoji Sanomura; Shigeto Yoshida; Koji Arihiro; Fumio Shimamoto; Kazuaki Chayama
Journal:  Gastric Cancer       Date:  2014-04-16       Impact factor: 7.370

9.  Characteristics of metachronous gastric tumors after endoscopic submucosal dissection for gastric intraepithelial neoplasms.

Authors:  Tomoyuki Boda; Masanori Ito; Shiro Oka; Yoko Kitamura; Norifumi Numata; Yoji Sanomura; Taiji Matsuo; Shinji Tanaka; Masaharu Yoshihara; Koji Arihiro; Kazuaki Chayama
Journal:  Gastroenterol Res Pract       Date:  2014-02-11       Impact factor: 2.260

10.  Continued use of low-dose aspirin does not increase the risk of bleeding during or after endoscopic submucosal dissection for early gastric cancer.

Authors:  Yoji Sanomura; Shiro Oka; Shinji Tanaka; Norifumi Numata; Makoto Higashiyama; Hiroyuki Kanao; Shigeto Yoshida; Yoshitaka Ueno; Kazuaki Chayama
Journal:  Gastric Cancer       Date:  2013-10-19       Impact factor: 7.370
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.